REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > O-glycoside > Dissacharide DissacharideDissacharide patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.02/01/07 - 20070027105 - Peroxide removal from drug delivery vehicle The present invention is related to methods for lowering peroxide levels in sucrose acetate isobutyrate formulations and to composition used in and formed by such methods. ... 01/04/07 - 20070004672 - Long lasting alginate dry eye, related methods of manufacture and methods of use The present invention is directed to a composition for treating dry eye comprising, in one embodiment, alginate and a polyol. Such compositions have been found to alleviate the symptoms of dry eye and remain in the eye for a long period of time. ... 01/04/07 - 20070004671 - Stable desloratadine compositions The present invention relates to stable pharmaceutical compositions of desloratadine comprising desloratadine in combination with a desloratadine-stabilizing amount of at least one amino acid. ... 12/28/06 - 20060293275 - Hgf production accelerator containing heparin-like oligosaccharide The present invention aims to provide an agent for promoting HGF production comprising, as an effective ingredient, a disaccharide comprised of an uronic acid residue (wherein an uronic acid means an iduronic acid or a glucuronic acid, and has the same meaning hereinafter) and a glucosamine residue that are connected ... 12/07/06 - 20060276429 - Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation with the proviso that when Z is —NHR13 and Y is O, at least one of R1, R2, R3, R4, and R5 is hydrogen, or at least one of R6 and R7 is OH, or a pharmaceutically acceptable salt thereof. ... 11/16/06 - 20060258616 - Natural semi-synthetic and synthetic lipid derivatives of ceramide and sphingosine groups, drugs and the medical use thereof in the form of therapeutic agents in particular for dermatology The subject of the present invention is new substances which are derived from naturally occurring ceramides and sphingosine and also from synthetic compounds with principally the same structure in that they represent dimers, trimers, tetramers etc., hence i.e. oligomers of the initial substances. ... 09/21/06 - 20060211650 - Reducing carbohydrate derivatives of adamantane amines, and synthesis and methods of use thereof The present invention relates to reducing carbohydrate derivatives of adamantane amines of Formula A or pharmaceutically acceptable salts, solvates or derivatives thereof, wherein R1, R2, R3, and R4 are together or separately H, F, methyl or lower alkyl, alkenyl, or alkynyl groups, and Z is derived from a mono-, di-, ... 05/18/06 - 20060105986 - Antimicrobial molecule The present invention relates to a compound having antimicrobial activities. The present invention also provides methods for the production and purification of flocculosin, the antimicrobial compound of the invention, including the steps of cultivating the microorganism Pseudozyma flocculosa. Analogs and derivatives of flocculosin are described herein. ... 05/11/06 - 20060100170 - Isopycnic pharmaceutical formulation The present invention is directed to pharmaceutical compositions comprising an aqueous solution in which the density of the aqueous solution is isopycnic or substantially isopycnic with a pharmaceutical agent. The present invention is also directed to methods for storing such pharmaceutical compositions and formulations, and to the use of such ... 05/04/06 - 20060094687 - Formulations Ecteinascidin formulations, methods of preparing the same, articles of manufacture and kits with such formulations, and methods of treating proliferative diseases with the same formulations are provided. ... 03/30/06 - 20060069062 - Diructose anhydride-containing composition and use thereof The present invention relates to a difructose anhydride (DFA)-containing composition and use thereof. DFA is a cyclic disaccharide in which the reducing termini of two fructose molecules bind each other to hydroxyl groups at the other nonreducing termini. According to the present invention, it has been revealed that DFA is ... 03/02/06 - 20060046973 - Compositions containing 5-amino-2-hydroxybenzoic acid and a reducing sugar Compositions comprising 5-amino-2-hydroxybenzoic acid (5-amino salicylic acid, mesalamine) and a reducing sugar, e.g., lactose, undergo the Maillard and other chemical reactions and produce, in the case of lactose, a degradant 5-[2-Formyl-5-(hydroxymethyl)-1H-pyrrol-1-yl]-2-hydroxybenzoic acid. Inventors have developed means to contain and/or reduce the formation of degradants of 5-amino-2-hydroxybenzoic acid. ... 12/15/05 - 20050277617 - Drugs against articular failure The object of the present invention is to provide a composition which exerts a higher effect on recovering health from articular disorders than that attained by amino sugars and glycosaminoglycans. The present invention solves the object by providing an agent for treating articular disorders, comprising an amino sugar and trehalose ... 12/08/05 - 20050272693 - Prophylactic and therapeutic treatment of infectious and other diseases with mono-and disaccharide-based compounds Methods and compositions for treating or ameliorating diseases and other conditions, such as infectious diseases, autoimmune diseases and allergies are provided. The methods employ mono- and disaccharide-based compounds for selectively stimulating immune responses in animals and plants. ... 12/08/05 - 20050272692 - Sucrose ester compounds useful as fungicides and X is selected from the group consisting of halogen, hydroxyl, and R. ... 12/01/05 - 20050267067 - Radical reaction inhibitors, method for inhibition of radical reactions, and use thereof The present invention has an object to provide a radical reaction inhibitory agent for inhibiting unsaturated compounds from decomposing through radical reactions, a method for inhibiting the formation of free radicals from unsaturated compounds and radical reactions thereof, and a composition which is suppressed in radical formation, radical reaction, or ... 11/10/05 - 20050250733 - Purified, moderately esterified polyol polyester fatty acid compositions Processes for the production of purified, moderately esterified polyol fatty acid polyesters and the compositions derived from those processes. The purified, moderately esterified polyol fatty acid polyesters are particularly well suited for use in a variety of food, beverage, pharmaceutical, and cosmetic applications. Purified, moderately esterified polyol fatty acid polyester ... 11/10/05 - 20050250732 - Purified, moderately esterified polyol polyester fatty acid compositions Processes for the production of purified, moderately esterified polyol fatty acid polyesters and the compositions derived from those processes. The purified, moderately esterified polyol fatty acid polyesters are particularly well suited for use in a variety of cosmetic, laundry, and industrial lubrication applications. The purified, moderately esterified polyol fatty acid ... 11/10/05 - 20050250731 - Synthesis of purified, moderately esterified polyol polyester fatty acid compositions Processes for the preparation of a purified moderately esterified polyol fatty acid polyester composition including the steps of: forming an initial reaction mixture containing a polyol portion, a highly esterified polyol fatty acid polyester, a moderately esterified polyol fatty acid polyester; and a catalyst; wherein the molar ratio of the ... 10/27/05 - 20050239740 - Hydrazide-containing cftr inhibitor compounds and uses thereof The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for the study and treatment of CFTR-mediated diseases and conditions. The compositions and pharmaceutical preparations of the invention may comprise one or more hydrazide-containing compounds, and may additionally comprise ... 09/22/05 - 20050209187 - Iron sucrose complexes and method of manufacture thereof A process is provided for preparing an iron sucrose complex, substantially free of excipients, for providing an iron sucrose complex co-precipitated with sucrose, and for providing iron sucrose complexes in aqueous solution. ... 09/08/05 - 20050197317 - Methods for using polyol esters to control pests Methods are disclosed for killing or knocking down pests selected from the group consisting of cockroaches, ants, bristletails, wasps, hornets, crickets, earwigs, centipedes, scorpions, sowbugs, pillbugs, and spiders. One sprays the pest directly with a solution that is at least 2.8% ester of a polyol (such as sucrose octanoate or ... 08/04/05 - 20050171052 - Sucrose acetate isobutyrate formulation The present invention provides a solid sucrose acetate isobutyrate formulation having improved handling characteristics. ... 07/28/05 - 20050164978 - Method for normalizing insulin levels The invention is directed to a dietary supplement which contains mannoheptulose. Mannoheptulose occurs naturally in avocado fruit. The dietary supplement and its method of use can lower serum insulin levels and lower a subject's weight. The dietary supplement in its disclosed form includes a controlled release system for mannoheptulose. The ... 06/30/05 - 20050143341 - Novel substance having physiological property, method for producing the same and uses thereof (wherein Sug represents a glucose residue or a sugar linkage composed of two or more glucose units) as an aglycon, a physiologically active substance containing the glucoside having human cytokine inducing ability increasing activity, a method for producing it, and food, medicine and feedstuff containing the substance. ... ### FreshPatents.com Support |